Business Context and Reporting Period
This Form 6-K filing by GSK plc covers the month of August 2022. The report serves as a notification to the market regarding the Company's total voting rights and capital structure in conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a capital structure notification and contains no financial performance data.
Capital Structure Details
- Issued Share Capital (as of 31 July 2022): 4,311,277,892 Ordinary Shares of 31 1/4 pence each.
- Treasury Shares: 243,924,760 Ordinary Shares.
- Total Voting Rights: 4,067,353,132.
Material Changes
The filing text does not provide a clear value for material changes versus a prior comparable period. The document reports a static snapshot of share capital as of 31 July 2022 without comparative historical data.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of voting rights for shareholder notification purposes.
Investor Verification Checklist
- Verify the total number of voting rights (4,067,353,132) to determine if notification thresholds under FCA rules are met.
- Confirm the number of shares held in Treasury (243,924,760) when calculating the denominator for ownership percentages.
- Check the Company Secretary contact (company.secretary@gsk.com) for submitting interest notifications.